Report Content
Chapter 1 Methodology & Scope
1.1 Market scope & definition
1.2 Base estimates & workings
1.3 Forecast calculations
1.4 Data Sources
1.4.1 Primary
1.4.2 Secondary
1.4.2.1 Paid sources
1.4.2.2 Unpaid sources
Chapter 2 Executive Summary
2.1 Global fecal occult testing market 360° synopsis, 2018 – 2032
2.2 Regional trends
2.3 Test type trends
2.4 End-use trends
Chapter 3 Fecal Occult Testing Industry Insights
3.1 COVID- 19 impact analysis
3.2 Industry ecosystem analysis
3.3 Technology landscape
3.4 Regulatory landscape
3.5 Industry impact forces
3.5.1 Growth drivers
3.5.1.1 Increasing prevalence of rectal & colon cancer
3.5.1.2 Growing government initiatives towards colorectal cancer
3.5.1.3 Surge in point of care testing and non-invasive tests
3.5.1.4 Technological advancements
3.5.2 Industry pitfalls & challenges
3.5.2.1 High cost of testing
3.5.2.2 Lack of awareness regarding fecal occult testing
3.6 Growth potential analysis
3.6.1 By test type
3.6.2 By end-use
3.7 Porter's analysis
3.8 PESTEL analysis
Chapter 4 Competitive Landscape, 2022
4.1 Introduction
4.1.1 Biopanda Reagents Ltd
4.1.2 HUMASIS.COM
4.1.3 CTK Biotech, Inc.
4.2 Competitive analysis of major market players, 2022
4.3 Competitive positioning matrix, 2022
4.4 Strategic outlook matrix, 2022
Chapter 5 Fecal Occult Testing Market Estimates and Forecast, By Test Type (Revenue and Volume)
5.1 Key trends, by test type
5.2 Guaiac FOB stool test
5.3 Immuno-FOB agglutination test
5.4 Lateral flow immuno-FOB test
5.5 Immuno-FOB ELISA test
Chapter 6 Fecal Occult Testing Market Estimates and Forecast, By End-use (Revenue)
6.1 Key trends, by end-use
6.2 Hospitals
6.3 Diagnostic centers
6.4 Others
Chapter 7 Fecal Occult Testing Market Estimates and Forecast, By Region (Revenue and Volume)
7.1 Key trends, by region
7.2 North America
7.2.1 U.S.
7.2.2 Canada
7.3 Europe
7.3.1 Germany
7.3.2 UK
7.3.3 France
7.3.4 Italy
7.3.5 Spain
7.3.6 Switzerland
7.3.7 The Netherlands
7.3.8 Denmark
7.3.9 Poland
7.3.10 Sweden
7.4 Asia Pacific
7.4.1 China
7.4.2 Japan
7.4.3 India
7.4.4 Australia
7.4.5 South Korea
7.4.6 New Zealand
7.4.7 Thailand
7.4.8 Vietnam
7.4.9 Indonesia
7.5 Latin America
7.5.1 Brazil
7.5.2 Mexico
7.5.3 Argentina
7.5.4 Colombia
7.5.5 Chile
7.6 Middle East & Africa
7.6.1 Saudi Arabia
7.6.2 South Africa
7.6.3 UAE
7.6.4 Turkey
Chapter 8 Company Profiles
8.1 Biopanda Reagents Ltd
8.2 HUMASIS.COM
8.3 CTK Biotech, Inc.
8.4 Biohit Oyj
8.5 CERTEST BIOTEC
8.6 Alfa Scientific Designs, Inc.
8.7 Cenogenics Corporation
8.8 Jant Pharmacal Corporation.
8.9 Quidel Corporation
8.10 Wondfo.
8.11 Siemens Healthcare GmbH
